OFLOCET Side Effects

6920819-2 | Vitamin K Deficiency
on Aug 05, 2010 Male patient from FRANCE , 67 years of age, was treated with Oflocet (View Usage). Patient experienced the following unwanted or unexpected effects: vitamin k deficiency. Oflocet dosage: . During the same period patient was treated with RIFADIN (View Rifadin Review and Rifadin Label ), DALACIN (View Dalacin Review and Dalacin Label ), ORBENIN CAP (View Orbenin Cap Review and Orbenin Cap Label ), GENTALLINE (View Gentalline Review and Gentalline Label ), CEFROM (View Cefrom Review and Cefrom Label ), HEPARIN (View Heparin Review and Heparin Label ). Patient was hospitalized.

6653286-7 | Anti Factor Vii Antibody Positive, Prothrombin Time Prolonged
Patient was taking Oflocet (View Usage). Patient had the following side effects: anti factor vii antibody positive, prothrombin time prolonged on Mar 17, 2010 from FRANCE Additional patient health information: Male patient , 58 years of age, . Oflocet dosage: . During the same period patient was treated with CLAFORAN (View Claforan Review and Claforan Label ), HUMAN FIBRINOGEN+HUMAN THROMBIN (View Human Fibrinogen+human Thrombin Review and Human Fibrinogen+human Thrombin Label ). Patient was hospitalized.

6576960-X | Anaphylactic Shock
Adverse event was reported on Mar 18, 2009 by a Male patient taking Oflocet (View Usage) (Dosage: ) was diagnosed with urinary tract infection (What is urinary tract infection?) and. Location: JAPAN , 50 years of age, After Oflocet was administered, patient had the following side effects: anaphylactic shock. During the same period patient was treated with DIPRIVAN (View Diprivan Review and Diprivan Label ), ERYTHROMYCIN (View Erythromycin Review and Erythromycin Label ), NEXIUM (View Nexium Review and Nexium Label ), LOVENOX (View Lovenox Review and Lovenox Label ), BRISTOPEN (View Bristopen Review and Bristopen Label ). Patient was hospitalized.

6576959-3 | Cholestasis
on Feb 23, 2009 Male patient from JAPAN , 75 years of age, was treated with Oflocet (View Usage). Patient experienced the following unwanted or unexpected effects: cholestasis. Oflocet dosage: . During the same period patient was treated with FLAGYL (View Flagyl Review and Flagyl Label ), TAZOCILLINE (View Tazocilline Review and Tazocilline Label ), FORTUM (View Fortum Review and Fortum Label ), CANCIDAS (View Cancidas Review and Cancidas Label ), NEUPOGEN (1 U) (View Neupogen Review and Neupogen Label ), NEXIUM (View Nexium Review and Nexium Label ), PERFALGAN (As Needed) (View Perfalgan Review and Perfalgan Label ), GLUCONATE DE CALCIUM (2 U) (View Gluconate De Calcium Review and Gluconate De Calcium Label ).


6576958-1 | Atrial Fibrillation, Stevens-johnson Syndrome, Tendon Disorder
on Jan 28, 2009 Male patient from JAPAN , 71 years of age, was diagnosed with bone marrow failure, pyrexia, myeloid leukaemia and was treated with Oflocet (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), stevens-johnson syndrome, tendon disorder. Oflocet dosage: . During the same period patient was treated with ZAVEDOS (80 Mg/m**2) (View Zavedos Review and Zavedos Label ), ARACYTINE (100 Mg/m**2) (View Aracytine Review and Aracytine Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ), TIENAM (View Tienam Review and Tienam Label ), VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), NEBILOX (View Nebilox Review and Nebilox Label ).

6539312-4 | Agranulocytosis, Cardiac Failure, Rash, Renal Failure Acute
Patient was taking Oflocet (View Usage). After Oflocet was administered, patient had the following side effects: agranulocytosis, cardiac failure, rash (What is rash?), renal failure acute on Jan 12, 2010 from JAPAN Additional patient health information: Female patient , 84 years of age, was diagnosed with lung disorder and. Oflocet dosage: . During the same period patient was treated with ROCEPHIN (View Rocephin Review and Rocephin Label ), TAVANIC (View Tavanic Review and Tavanic Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ). Patient was hospitalized.

6269781-9 | Blood Lactate Dehydrogenase Increased, Cytolytic Hepatitis, Hypotension, Myalgia, Nausea, Pancytopenia, Pyrexia, Rash
Adverse event was reported on Jul 13, 2009 by a Female patient taking Oflocet (View Usage) (Dosage: ) was diagnosed with cystitis bacterial and. Location: JAPAN , 41 years of age, Patient experienced the following unwanted or unexpected effects: blood lactate dehydrogenase increased, cytolytic hepatitis, hypotension, myalgia, nausea (What is nausea?), pancytopenia, pyrexia, rash (What is rash?). During the same period patient was treated with BACTRIM (2 Units) (View Bactrim Review and Bactrim Label ). Patient was hospitalized.

6269183-5 | Anaphylactic Reaction, Erythema, Hypotension, Tachycardia
on Jul 08, 2009 Female patient from JAPAN , 77 years of age, was diagnosed with sigmoiditis, diverticulitis and was treated with Oflocet (View Usage). Patient had the following side effects: anaphylactic reaction, erythema, hypotension, tachycardia. Oflocet dosage: . During the same period patient was treated with SUFENTANIL (View Sufentanil Review and Sufentanil Label ), FLAGYL (View Flagyl Review and Flagyl Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ), NIMBEX (View Nimbex Review and Nimbex Label ), AUGMENTIN (View Augmentin Review and Augmentin Label ). Patient was hospitalized.

6268594-1 | Bicytopenia, Haemoptysis, Hepatitis Cholestatic, Neutropenia, Rhabdomyolysis, Thrombocytopenia
on Jul 02, 2009 Male patient from JAPAN , 74 years of age, was treated with Oflocet (View Usage). After Oflocet was administered, patient had the following side effects: bicytopenia, haemoptysis, hepatitis cholestatic, neutropenia, rhabdomyolysis, thrombocytopenia. Oflocet dosage: . During the same period patient was treated with TAZOCILLINE (View Tazocilline Review and Tazocilline Label ), PULMICORT 100 (View Pulmicort-100 Review and Pulmicort-100 Label ), TAHOR (View Tahor Review and Tahor Label ), OMIX (View Omix Review and Omix Label ), KARDEGIC (View Kardegic Review and Kardegic Label ). Patient was hospitalized.

6266841-3 | Bicytopenia, Leukopenia, Thrombocytopenia
Patient was taking Oflocet (View Usage). Patient experienced the following unwanted or unexpected effects: bicytopenia, leukopenia, thrombocytopenia on Jul 09, 2009 from JAPAN Additional patient health information: Female patient , 77 years of age, . Oflocet dosage: . During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ), XANAX (View Xanax Review and Xanax Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), NEXIUM (View Nexium Review and Nexium Label ). Patient was hospitalized.

6266840-1 | Cholestasis
Adverse event was reported on Jul 09, 2009 by a Male patient taking Oflocet (View Usage) (Dosage: ) was diagnosed with lower respiratory tract infection bacterial and. Location: JAPAN , 89 years of age, Patient had the following side effects: cholestasis. During the same period patient was treated with CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), GLUCIDION (View Glucidion Review and Glucidion Label ), CALCIPARINE (View Calciparine Review and Calciparine Label ), SPECIAFOLDINE (View Speciafoldine Review and Speciafoldine Label ), FORADIL (View Foradil Review and Foradil Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), DIFFU K (View Diffu K Review and Diffu K Label ), NEXIUM (View Nexium Review and Nexium Label ). Patient was hospitalized.

6264022-0 | Anaphylactic Reaction, Erythema, Hypotension, Tachycardia
on Jul 08, 2009 Female patient from JAPAN , 77 years of age, was diagnosed with sigmoiditis, diverticulitis and was treated with Oflocet (View Usage). After Oflocet was administered, patient had the following side effects: anaphylactic reaction, erythema, hypotension, tachycardia. Oflocet dosage: . During the same period patient was treated with SUFENTANIL (View Sufentanil Review and Sufentanil Label ), FLAGYL (View Flagyl Review and Flagyl Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ), NIMBEX (View Nimbex Review and Nimbex Label ), AUGMENTIN (View Augmentin Review and Augmentin Label ). Patient was hospitalized.

6256653-9 | Bicytopenia, Haemoptysis, Hepatitis Cholestatic, Neutropenia, Rhabdomyolysis, Thrombocytopenia
on Jul 02, 2009 Male patient from JAPAN , 74 years of age, was treated with Oflocet (View Usage). Patient experienced the following unwanted or unexpected effects: bicytopenia, haemoptysis, hepatitis cholestatic, neutropenia, rhabdomyolysis, thrombocytopenia. Oflocet dosage: . During the same period patient was treated with TAZOCILLINE (View Tazocilline Review and Tazocilline Label ), PULMICORT 100 (View Pulmicort-100 Review and Pulmicort-100 Label ), TAHOR (View Tahor Review and Tahor Label ), OMIX (View Omix Review and Omix Label ), KARDEGIC (View Kardegic Review and Kardegic Label ). Patient was hospitalized.

6246242-4 | Eosinophilia, Toxic Skin Eruption
Patient was taking Oflocet (View Usage). Patient had the following side effects: eosinophilia, toxic skin eruption on Jun 23, 2009 from JAPAN Additional patient health information: Female patient , 46 years of age, was diagnosed with viral infection (What is viral infection?), epilepsy (What is epilepsy?) and. Oflocet dosage: . During the same period patient was treated with COQUELUSEDAL (View Coquelusedal Review and Coquelusedal Label ), RHINOFLUIMUCIL (View Rhinofluimucil Review and Rhinofluimucil Label ), BRONCHODUAL (View Bronchodual Review and Bronchodual Label ), EXOMUC (View Exomuc Review and Exomuc Label ), NEOCODION (View Neocodion Review and Neocodion Label ), HEXAPNEUMINE /01424801/ (View Hexapneumine /01424801/ Review and Hexapneumine /01424801/ Label ), DEPAKENE (View Depakene Review and Depakene Label ). Patient was hospitalized.

6240160-3 | International Normalised Ratio Increased
Adverse event was reported on Jun 18, 2009 by a Female patient taking Oflocet (View Usage) (Dosage: ) was diagnosed with sepsis (What is sepsis?), fungal infection (What is fungal infection?), deep vein thrombosis (What is deep vein thrombosis?), thrombosis prophylaxis, constipation (What is constipation?), hypertensive heart disease and. Location: JAPAN , 75 years of age, After Oflocet was administered, patient had the following side effects: international normalised ratio increased. During the same period patient was treated with TRIFLUCAN (View Triflucan Review and Triflucan Label ), COUMADIN (View Coumadin Review and Coumadin Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), LYRICA (View Lyrica Review and Lyrica Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), PARAFFIN (View Paraffin Review and Paraffin Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ). Patient was hospitalized.

6234257-1 | Eosinophilia, Renal Failure Acute
on Jun 15, 2009 Male patient from JAPAN , 61 years of age, was diagnosed with sepsis (What is sepsis?) and was treated with Oflocet (View Usage). Patient experienced the following unwanted or unexpected effects: eosinophilia, renal failure acute. Oflocet dosage: . During the same period patient was treated with RIFADIN (View Rifadin Review and Rifadin Label ), VANCOMYCINE (View Vancomycine Review and Vancomycine Label ), ORBENIN CAP (View Orbenin Cap Review and Orbenin Cap Label ), DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), PROZAC (View Prozac Review and Prozac Label ), XATRAL (View Xatral Review and Xatral Label ), SERENOA REPENS (View Serenoa Repens Review and Serenoa Repens Label ). Patient was hospitalized.

6217807-0 | Thrombocytopenia
on Jun 05, 2009 Male patient from JAPAN , 54 years of age, was diagnosed with agranulocytosis, hiv test positive (What is hiv test positive?) and was treated with Oflocet (View Usage). Patient had the following side effects: thrombocytopenia. Oflocet dosage: . During the same period patient was treated with AUGMENTIN (View Augmentin Review and Augmentin Label ), COMBIVIR (View Combivir Review and Combivir Label ), KALETRA (View Kaletra Review and Kaletra Label ). Patient was hospitalized.

6212784-0 | Gait Disturbance, Pain In Extremity
Patient was taking Oflocet (View Usage). After Oflocet was administered, patient had the following side effects: gait disturbance, pain in extremity on Jun 02, 2009 from JAPAN Additional patient health information: Male patient , 85 years of age, was diagnosed with prostatitis and. Oflocet dosage: 3 Weeks. During the same period patient was treated with STATINS (View Statins Review and Statins Label ).

6211568-7 | Eosinophilia, Pruritus, Rash Erythematous, Skin Lesion
Adverse event was reported on May 29, 2009 by a Male patient taking Oflocet (View Usage) (Dosage: ) was diagnosed with staphylococcal infection (What is staphylococcal infection?) and. Location: JAPAN , 88 years of age, Patient experienced the following unwanted or unexpected effects: eosinophilia, pruritus, rash erythematous, skin lesion. During the same period patient was treated with FUSIDATE SODIUM (View Fusidate Sodium Review and Fusidate Sodium Label ), NEXIUM (View Nexium Review and Nexium Label ), CASODEX (View Casodex Review and Casodex Label ), HEMIGOXINE NATIVELLE (View Hemigoxine Nativelle Review and Hemigoxine Nativelle Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ), LASIX (View Lasix Review and Lasix Label ), OXACILLIN (View Oxacillin Review and Oxacillin Label ). Patient was hospitalized.

6208310-2 | Haematuria, Hypoprothrombinaemia, Metrorrhagia, Rectal Haemorrhage, Renal Haematoma
on May 21, 2009 Female patient from JAPAN , 70 years of age, was diagnosed with haematuria, atrial fibrillation (What is atrial fibrillation?) and was treated with Oflocet (View Usage). Patient had the following side effects: haematuria, hypoprothrombinaemia, metrorrhagia, rectal haemorrhage, renal haematoma. Oflocet dosage: . During the same period patient was treated with FLUINDIONE (View Fluindione Review and Fluindione Label ), CORDARONE (View Cordarone Review and Cordarone Label ), HEMIGOXINE (View Hemigoxine Review and Hemigoxine Label ), ELISOR (View Elisor Review and Elisor Label ). Patient was hospitalized.

6125311-3 | Anaphylactic Shock
on Mar 18, 2009 Male patient from JAPAN , 50 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Oflocet (View Usage). After Oflocet was administered, patient had the following side effects: anaphylactic shock. Oflocet dosage: . During the same period patient was treated with DIPRIVAN (View Diprivan Review and Diprivan Label ), ERYTHROMYCIN (View Erythromycin Review and Erythromycin Label ), NEXIUM (View Nexium Review and Nexium Label ), LOVENOX (View Lovenox Review and Lovenox Label ), BRISTOPEN (View Bristopen Review and Bristopen Label ). Patient was hospitalized.

6123661-8 | Eyelid Oedema, Rash Maculo-papular
Patient was taking Oflocet (View Usage). Patient experienced the following unwanted or unexpected effects: eyelid oedema, rash maculo-papular on Mar 13, 2009 from JAPAN Additional patient health information: Female patient , 31 years of age, was diagnosed with osteitis and. Oflocet dosage: . During the same period patient was treated with CLAMOXYL (View Clamoxyl Review and Clamoxyl Label ), DALACINE (View Dalacine Review and Dalacine Label ), VANCOMYCINE (View Vancomycine Review and Vancomycine Label ), TARGOCID (View Targocid Review and Targocid Label ), CLAVENTIN (View Claventin Review and Claventin Label ).

6108771-3 | Confusional State, Hallucination, Myoclonus, Renal Failure
Adverse event was reported on Mar 05, 2009 by a Male patient taking Oflocet (View Usage) (Dosage: ) was diagnosed with aortic valve replacement and. Location: JAPAN , 76 years of age, Patient had the following side effects: confusional state, hallucination, myoclonus, renal failure. During the same period patient was treated with DITROPAN (View Ditropan Review and Ditropan Label ), EFFERALGAN (View Efferalgan Review and Efferalgan Label ), INIPOMP (View Inipomp Review and Inipomp Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), XATRAL (View Xatral Review and Xatral Label ), ACTISKENAN (View Actiskenan Review and Actiskenan Label ), NICARDIPINE HCL (View Nicardipine Hcl Review and Nicardipine Hcl Label ), TOPLEXIL (View Toplexil Review and Toplexil Label ). Patient was hospitalized.

6100896-1 | Arthralgia, Erysipelas, Toxic Skin Eruption
on Mar 03, 2009 Female patient from JAPAN , 67 years of age, was diagnosed with infection prophylaxis, procedural pain and was treated with Oflocet (View Usage). After Oflocet was administered, patient had the following side effects: arthralgia, erysipelas, toxic skin eruption. Oflocet dosage: . During the same period patient was treated with PROFENID (View Profenid Review and Profenid Label ), BIPROFENID (View Biprofenid Review and Biprofenid Label ), PYOSTACINE (View Pyostacine Review and Pyostacine Label ), LOVENOX (View Lovenox Review and Lovenox Label ), CETIRIZINE WINTHROP (View Cetirizine Winthrop Review and Cetirizine Winthrop Label ). Patient was hospitalized.

6094866-X | Leukopenia, Pyrexia, Toxic Skin Eruption
on Feb 23, 2009 Male patient from JAPAN , 46 years of age, was diagnosed with abscess limb and was treated with Oflocet (View Usage). Patient experienced the following unwanted or unexpected effects: leukopenia, pyrexia, toxic skin eruption. Oflocet dosage: . During the same period patient was treated with RIFADIN (View Rifadin Review and Rifadin Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ), PLAQUENIL (View Plaquenil Review and Plaquenil Label ), MOPRAL (View Mopral Review and Mopral Label ), MINISINTROM (View Minisintrom Review and Minisintrom Label ). Patient was hospitalized.

6094052-3 | Arthralgia, Erysipelas, Toxic Skin Eruption
Patient was taking Oflocet (View Usage). Patient had the following side effects: arthralgia, erysipelas, toxic skin eruption on Feb 23, 2009 from JAPAN Additional patient health information: Female patient , 67 years of age, was diagnosed with infection prophylaxis, procedural pain and. Oflocet dosage: . During the same period patient was treated with PROFENID (View Profenid Review and Profenid Label ), BIPROFENID (View Biprofenid Review and Biprofenid Label ), PYOSTACINE (View Pyostacine Review and Pyostacine Label ), LOVENOX (View Lovenox Review and Lovenox Label ), CETIRIZINE WINTHROP (View Cetirizine Winthrop Review and Cetirizine Winthrop Label ). Patient was hospitalized.

6093117-X | Haematoma, Peroneal Nerve Palsy, Tendon Rupture
Adverse event was reported on Feb 19, 2009 by a Female patient taking Oflocet (View Usage) (Dosage: ) was diagnosed with klebsiella infection, glaucoma (What is glaucoma?) and. Location: JAPAN , 80 years of age, After Oflocet was administered, patient had the following side effects: haematoma, peroneal nerve palsy, tendon rupture. During the same period patient was treated with CORTANCYL (View Cortancyl Review and Cortancyl Label ), CORDARONE (1 U) (View Cordarone Review and Cordarone Label ), MINISINTROM (View Minisintrom Review and Minisintrom Label ), TIMOPTIC (View Timoptic Review and Timoptic Label ), AZOPT (1 U Eye Drops) (View Azopt Review and Azopt Label ), ANAFRANIL (View Anafranil Review and Anafranil Label ), MOPRAL (View Mopral Review and Mopral Label ), FONZYLANE (View Fonzylane Review and Fonzylane Label ). Patient was hospitalized.

6092751-0 | Alanine Aminotransferase Increased, Alopecia, Arthralgia, Azoospermia, Balanitis Candida, Confusional State, Diplopia, Dysgeusia
on Feb 12, 2009 Male patient from JAPAN , 34 years of age, was diagnosed with pyelonephritis acute, urinary tract infection (What is urinary tract infection?), prostatitis, atrial fibrillation (What is atrial fibrillation?), bronchitis (What is bronchitis?) and was treated with Oflocet (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, alopecia, arthralgia, azoospermia, balanitis candida, confusional state, diplopia, dysgeusia. Oflocet dosage: . During the same period patient was treated with PREVISCAN (View Previscan Review and Previscan Label ), FLECAINE (View Flecaine Review and Flecaine Label ), SOLUPRED (View Solupred Review and Solupred Label ), AUGMENTIN (View Augmentin Review and Augmentin Label ). Patient was hospitalized and became disabled.

6091084-6 | Cholestasis
on Feb 23, 2009 Male patient from JAPAN , 75 years of age, was treated with Oflocet (View Usage). Patient had the following side effects: cholestasis. Oflocet dosage: . During the same period patient was treated with FLAGYL (View Flagyl Review and Flagyl Label ), TAZOCILLINE (View Tazocilline Review and Tazocilline Label ), FORTUM (View Fortum Review and Fortum Label ), CANCIDAS (View Cancidas Review and Cancidas Label ), NEUPOGEN (1 U) (View Neupogen Review and Neupogen Label ), NEXIUM (View Nexium Review and Nexium Label ), PERFALGAN (As Needed) (View Perfalgan Review and Perfalgan Label ), GLUCONATE DE CALCIUM (2 U) (View Gluconate De Calcium Review and Gluconate De Calcium Label ).

6091083-4 | Acute Coronary Syndrome, Renal Failure
Patient was taking Oflocet (View Usage). After Oflocet was administered, patient had the following side effects: acute coronary syndrome, renal failure on Feb 16, 2009 from JAPAN Additional patient health information: Female patient , 88 years of age, . Oflocet dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), COVERSYL (View Coversyl Review and Coversyl Label ), TAHOR (View Tahor Review and Tahor Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ). Patient was hospitalized.

6091082-2 | Infertility
Adverse event was reported on Feb 12, 2009 by a Male patient taking Oflocet (View Usage) (Dosage: ) . Location: JAPAN , 37 years of age, Patient experienced the following unwanted or unexpected effects: infertility (What is infertility?).

6086494-7 | Renal Failure Acute, Septic Shock
on Feb 19, 2009 Male patient from JAPAN , 91 years of age, was diagnosed with intervertebral discitis and was treated with Oflocet (View Usage). Patient had the following side effects: renal failure acute, septic shock. Oflocet dosage: . During the same period patient was treated with RIFADIN (View Rifadin Review and Rifadin Label ). Patient was hospitalized.

6083211-1 | Anaemia, Muscular Weakness, Paresis, Renal Failure, Rhabdomyolysis
on Feb 05, 2009 Female patient from JAPAN , 67 years of age, weighting 240.3 lb, was treated with Oflocet (View Usage). After Oflocet was administered, patient had the following side effects: anaemia, muscular weakness, paresis, renal failure, rhabdomyolysis. Oflocet dosage: . During the same period patient was treated with VASTEN (View Vasten Review and Vasten Label ), CORDARONE (View Cordarone Review and Cordarone Label ), ROCEPHIN (2g Solution For Infusion) (View Rocephin Review and Rocephin Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), AMLOR (View Amlor Review and Amlor Label ), TENORMIN (View Tenormin Review and Tenormin Label ), NEORAL (View Neoral Review and Neoral Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

6081347-2 | Alanine Aminotransferase Increased, Alopecia, Arthralgia, Azoospermia, Balanitis Candida, Confusional State, Diplopia, Dysgeusia
Patient was taking Oflocet (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, alopecia, arthralgia, azoospermia, balanitis candida, confusional state, diplopia, dysgeusia on Feb 12, 2009 from JAPAN Additional patient health information: Male patient , 34 years of age, was diagnosed with pyelonephritis acute, urinary tract infection (What is urinary tract infection?), prostatitis, atrial fibrillation (What is atrial fibrillation?), bronchitis (What is bronchitis?) and. Oflocet dosage: . During the same period patient was treated with PREVISCAN (View Previscan Review and Previscan Label ), FLECAINE (View Flecaine Review and Flecaine Label ), SOLUPRED (View Solupred Review and Solupred Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ). Patient was hospitalized and became disabled.

6081346-0 | Oedema Peripheral, Pain, Tendonitis
Adverse event was reported on Feb 10, 2009 by a Male patient taking Oflocet (View Usage) (Dosage: ) was diagnosed with tooth infection, hypertension, coronary artery disease (What is coronary artery disease?) and. Location: JAPAN , 85 years of age, Patient had the following side effects: oedema peripheral, pain (What is pain?), tendonitis. During the same period patient was treated with IRBESARTAN (300) (View Irbesartan Review and Irbesartan Label ), VERAPAMIL (240) (View Verapamil Review and Verapamil Label ), KARDEGIC (View Kardegic Review and Kardegic Label ).

6074726-0 | Anaemia, Muscular Weakness, Paresis, Renal Failure, Rhabdomyolysis
on Feb 05, 2009 Female patient from JAPAN , 67 years of age, was treated with Oflocet (View Usage). After Oflocet was administered, patient had the following side effects: anaemia, muscular weakness, paresis, renal failure, rhabdomyolysis. Oflocet dosage: . During the same period patient was treated with VASTEN (View Vasten Review and Vasten Label ), CORDARONE (View Cordarone Review and Cordarone Label ), ROCEPHIN (2g Solution For Infusion) (View Rocephin Review and Rocephin Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), AMLOD (View Amlod Review and Amlod Label ), TENORMIN (View Tenormin Review and Tenormin Label ), NEORAL (View Neoral Review and Neoral Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ). Patient was hospitalized.

6071617-6 | Haematoma, Peroneal Nerve Palsy, Tendon Rupture
on Feb 05, 2009 Female patient from JAPAN , 80 years of age, was diagnosed with klebsiella infection, glaucoma (What is glaucoma?) and was treated with Oflocet (View Usage). Patient experienced the following unwanted or unexpected effects: haematoma, peroneal nerve palsy, tendon rupture. Oflocet dosage: . During the same period patient was treated with CORTANCYL (View Cortancyl Review and Cortancyl Label ), CORDARONE (1 U) (View Cordarone Review and Cordarone Label ), MINISINTROM (View Minisintrom Review and Minisintrom Label ), TIMOPTIC (View Timoptic Review and Timoptic Label ), AZOPT (1 U Eye Drops) (View Azopt Review and Azopt Label ), ANAFRANIL (View Anafranil Review and Anafranil Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), FONZYLANE (View Fonzylane Review and Fonzylane Label ). Patient was hospitalized.

6066843-6 | Atrial Fibrillation, Stevens-johnson Syndrome, Tendon Disorder
Patient was taking Oflocet (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), stevens-johnson syndrome, tendon disorder on Jan 28, 2009 from JAPAN Additional patient health information: Male patient , 71 years of age, was diagnosed with bone marrow failure, pyrexia, myeloid leukaemia and. Oflocet dosage: . During the same period patient was treated with ZAVEDOS (80 Mg/m**2) (View Zavedos Review and Zavedos Label ), CYTARABINE (100 Mg/m**2) (View Cytarabine Review and Cytarabine Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ), TIENAM (View Tienam Review and Tienam Label ), VANCOMYCINE (View Vancomycine Review and Vancomycine Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), NEBILOX (View Nebilox Review and Nebilox Label ).

6065844-1 | Cardiac Failure, Status Epilepticus
Adverse event was reported on Jan 27, 2009 by a Female patient taking Oflocet (View Usage) (Dosage: Film Coated Tablets) was diagnosed with pyelonephritis, hypertension, glaucoma (What is glaucoma?), escherichia sepsis and. Location: JAPAN , 89 years of age, After Oflocet was administered, patient had the following side effects: cardiac failure, status epilepticus. During the same period patient was treated with ASPEGIC 325 (View Aspegic 325 Review and Aspegic 325 Label ), ALDACTAZINE (Dose-0.5u) (View Aldactazine Review and Aldactazine Label ), TIMOPTIC (View Timoptic Review and Timoptic Label ), TANAKAN (View Tanakan Review and Tanakan Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ). Patient was hospitalized.

6065843-X | Cholestatic Liver Injury, Pericardial Effusion, Pleural Effusion, Pleuropericarditis
on Jan 26, 2009 Female patient from JAPAN , 58 years of age, was diagnosed with arthritis (What is arthritis?) and was treated with Oflocet (View Usage). Patient experienced the following unwanted or unexpected effects: cholestatic liver injury, pericardial effusion, pleural effusion, pleuropericarditis. Oflocet dosage: . During the same period patient was treated with RIFINAH (View Rifinah Review and Rifinah Label ), CARTREX (View Cartrex Review and Cartrex Label ), PYOSTACINE (View Pyostacine Review and Pyostacine Label ), LEVOTHYROX (View Levothyrox Review and Levothyrox Label ), COLCHICINE (View Colchicine Review and Colchicine Label ), NEXEN (View Nexen Review and Nexen Label ), INIPOMP (View Inipomp Review and Inipomp Label ). Patient was hospitalized.

6064909-8 | Headache, Nausea, Vertigo
on Jan 30, 2009 Male patient from JAPAN , 48 years of age, was diagnosed with bile duct stenosis and was treated with Oflocet (View Usage). Patient had the following side effects: headache (What is headache?), nausea (What is nausea?), vertigo. Oflocet dosage: . During the same period patient was treated with FLAGYL (View Flagyl Review and Flagyl Label ), TIBERAL (View Tiberal Review and Tiberal Label ), CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ). Patient was hospitalized.

6062439-0 | Coma, Convulsion, Necrosis Ischaemic, Renal Failure Acute, Renal Tubular Necrosis, Vomiting
Patient was taking Oflocet (View Usage). After Oflocet was administered, patient had the following side effects: coma, convulsion, necrosis ischaemic, renal failure acute, renal tubular necrosis, vomiting on Jan 30, 2009 from JAPAN Additional patient health information: Female patient , 82 years of age, was diagnosed with gastroenteritis (What is gastroenteritis?) and. Oflocet dosage: . During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ), LIPANTHYL (View Lipanthyl Review and Lipanthyl Label ), AINS (View Ains Review and Ains Label ), CALCIPARINE (View Calciparine Review and Calciparine Label ), NEXIUM (View Nexium Review and Nexium Label ), HALDOL (View Haldol Review and Haldol Label ). Patient was hospitalized.

5957668-8 | Interstitial Lung Disease, Pancytopenia, Pericardial Effusion, Pulmonary Embolism, Pyrexia, Sepsis
Adverse event was reported on Nov 12, 2008 by a Male patient taking Oflocet (View Usage) (Dosage: ) was diagnosed with pyrexia, acute promyelocytic leukaemia, prophylaxis of nausea and vomiting, hypoxia, dyspnoea and. Location: JAPAN , 74 years of age, Patient experienced the following unwanted or unexpected effects: interstitial lung disease, pancytopenia, pericardial effusion, pulmonary embolism (What is pulmonary embolism?), pyrexia, sepsis (What is sepsis?). During the same period patient was treated with TRISENOX (View Trisenox Review and Trisenox Label ), ZAVEDOS (5 Days/3 Days) (View Zavedos Review and Zavedos Label ), GRANOCYTE (View Granocyte Review and Granocyte Label ), ZOPHREN (View Zophren Review and Zophren Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ), VESANOID (View Vesanoid Review and Vesanoid Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ). Patient was hospitalized.

5954146-7 | Eosinophilia, Rash Papular
on Nov 11, 2008 Male patient from JAPAN , 71 years of age, was diagnosed with lung disorder, epilepsy (What is epilepsy?) and was treated with Oflocet (View Usage). Patient had the following side effects: eosinophilia, rash papular. Oflocet dosage: . During the same period patient was treated with KEPPRA (View Keppra Review and Keppra Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ), FUNGIZONE (View Fungizone Review and Fungizone Label ). Patient was hospitalized.

5951159-6 | Eosinophilia, Escherichia Bacteraemia, Hepatic Steatosis, Hyperthermia, Inflammation, Rash Erythematous, Rash Maculo-papular, Thrombocytopenia
on Nov 10, 2008 Male patient from JAPAN , 77 years of age, was diagnosed with prostatic disorder, pain (What is pain?) and was treated with Oflocet (View Usage). After Oflocet was administered, patient had the following side effects: eosinophilia, escherichia bacteraemia, hepatic steatosis, hyperthermia, inflammation, rash erythematous, rash maculo-papular, thrombocytopenia. Oflocet dosage: . During the same period patient was treated with NIFLURIL (View Nifluril Review and Nifluril Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ). Patient was hospitalized.

5949977-3 | Angioedema, Chest Discomfort, Dysphonia, Face Oedema, Muscle Contracture, Paraesthesia Oral
Patient was taking Oflocet (View Usage). Patient experienced the following unwanted or unexpected effects: angioedema, chest discomfort, dysphonia, face oedema, muscle contracture, paraesthesia oral on Nov 10, 2008 from JAPAN Additional patient health information: Male patient , 37 years of age, was diagnosed with prostatitis and. Oflocet dosage: . Patient was hospitalized.

5943664-3 | Sepsis, Thrombocytopenia
Adverse event was reported on Oct 30, 2008 by a Male patient taking Oflocet (View Usage) (Dosage: ) was diagnosed with sepsis (What is sepsis?) and. Location: JAPAN , 72 years of age, Patient had the following side effects: sepsis (What is sepsis?), thrombocytopenia. During the same period patient was treated with TRANXENE (View Tranxene Review and Tranxene Label ), BACTRIM (View Bactrim Review and Bactrim Label ), INNOHEP (View Innohep Review and Innohep Label ), NEXIUM (View Nexium Review and Nexium Label ), PERFALGAN (View Perfalgan Review and Perfalgan Label ), DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ). Patient was hospitalized.

5936880-8 | Arthralgia, Insomnia
on Oct 23, 2008 Male patient from JAPAN , 72 years of age, was diagnosed with sepsis (What is sepsis?), urinary tract infection (What is urinary tract infection?), hypertension and was treated with Oflocet (View Usage). After Oflocet was administered, patient had the following side effects: arthralgia, insomnia. Oflocet dosage: . During the same period patient was treated with OROKEN (View Oroken Review and Oroken Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ), FLUDEX (1 U Tablets) (View Fludex Review and Fludex Label ), ROSUVASTATIN CALCIUM (View Rosuvastatin Calcium Review and Rosuvastatin Calcium Label ), KALEORID (1 U Tablets) (View Kaleorid Review and Kaleorid Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ).

5898226-3 | Hepatitis Cholestatic, Lymphopenia
on Sep 17, 2008 Female patient from JAPAN , 94 years of age, was diagnosed with sepsis (What is sepsis?) and was treated with Oflocet (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis cholestatic, lymphopenia. Oflocet dosage: . Patient was hospitalized.

5886451-7 | Cholestasis, Cytolytic Hepatitis, Diarrhoea, Lymphadenopathy, Pulmonary Embolism
Patient was taking Oflocet (View Usage). Patient had the following side effects: cholestasis, cytolytic hepatitis, diarrhoea, lymphadenopathy, pulmonary embolism (What is pulmonary embolism?) on Sep 04, 2008 from JAPAN Additional patient health information: Female patient , 54 years of age, was diagnosed with pyrexia, hypothyroidism, peripheral vascular disorder, ovarian cancer, deep vein thrombosis (What is deep vein thrombosis?) and. Oflocet dosage: . During the same period patient was treated with AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), LEVOTHYROX (View Levothyrox Review and Levothyrox Label ), PREVISCAN (View Previscan Review and Previscan Label ), NORSET (View Norset Review and Norset Label ), MOPRAL (View Mopral Review and Mopral Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), INNOHEP (View Innohep Review and Innohep Label ).